These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 16895068)

  • 1. Cyclosporine A treatment of leprosy patients with chronic neuritis is associated with pain control and reduction in antibodies against nerve growth factor.
    Sena CB; Salgado CG; Tavares CM; Da Cruz CA; Xavier MB; Do Nascimento JL
    Lepr Rev; 2006 Jun; 77(2):121-9. PubMed ID: 16895068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to ciclosporin treatment in Ethiopian and Nepali patients with severe leprosy Type 1 reactions.
    Marlowe SN; Leekassa R; Bizuneh E; Knuutilla J; Ale P; Bhattarai B; Sigdel H; Anderson A; Nicholls PG; Johnston A; Holt D; Lockwood DN
    Trans R Soc Trop Med Hyg; 2007 Oct; 101(10):1004-12. PubMed ID: 17669450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Randomized controlled trial of medical and medico-surgical treatment of Hansen's neuritis].
    Boucher P; Millan J; Parent M; Moulia-Pela JP
    Acta Leprol; 1999; 11(4):171-7. PubMed ID: 10987048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological and clinical findings in leprosy patients with chronic neuropathic pain: a study from Hyderabad, India.
    Lund C; Koskinen M; Suneetha S; Lockwood DN; Haanpää M; Haapasalo H; Hietaharju A
    Lepr Rev; 2007 Dec; 78(4):369-80. PubMed ID: 18309711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.
    Liu HT; Tyagi P; Chancellor MB; Kuo HC
    BJU Int; 2009 Nov; 104(10):1476-81. PubMed ID: 19522864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent vs. continuous 1-year cyclosporin use in chronic plaque psoriasis.
    Chaidemenos GC; Mourellou O; Avgoustinaki N; Papakonstantinou M; Karakatsanis G; Katsambas A
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1203-8. PubMed ID: 17894706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary epidermal growth factor and interleukin-6 levels in patients with painful bladder syndrome/interstitial cystitis treated with cyclosporine or pentosan polysulfate sodium.
    Sairanen J; Hotakainen K; Tammela TL; Stenman UH; Ruutu M
    Urology; 2008 Apr; 71(4):630-3. PubMed ID: 18387391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potassium sensitivity test (PST) as a measurement of treatment efficacy of painful bladder syndrome/interstitial cystitis: a prospective study with cyclosporine A and pentosan polysulfate sodium.
    Sairanen J; Tammela TL; Leppilahti M; Onali M; Forsell T; Ruutu M
    Neurourol Urodyn; 2007; 26(2):267-70. PubMed ID: 17078084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment.
    Wilson SE; Perry HD
    Ophthalmology; 2007 Jan; 114(1):76-9. PubMed ID: 17070588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of alopecia areata in the DEBR model using Cyclosporin A lipid vesicles.
    Verma DD; Verma S; McElwee KJ; Freyschmidt-Paul P; Hoffman R; Fahr A
    Eur J Dermatol; 2004; 14(5):332-8. PubMed ID: 15358573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
    Alexopoulos E; Papagianni A; Tsamelashvili M; Leontsini M; Memmos D
    Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of budesonide mouthwash on oral chronic graft versus host disease.
    Sari I; Altuntas F; Kocyigit I; Sisman Y; Eser B; Unal A; Fen T; Ferahbas A; Ozturk A; Unal A; Cetin M
    Am J Hematol; 2007 May; 82(5):349-56. PubMed ID: 17109390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age is an important risk factor for onset and sequelae of reversal reactions in Vietnamese patients with leprosy.
    Ranque B; Nguyen VT; Vu HT; Nguyen TH; Nguyen NB; Pham XK; Schurr E; Abel L; Alcaïs A
    Clin Infect Dis; 2007 Jan; 44(1):33-40. PubMed ID: 17143812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of impairment in leprosy; results from a collaborative project in China.
    Smith WC; Zhang G; Zheng T; Watson JM; Lehman LF; Lever P
    Int J Lepr Other Mycobact Dis; 1995 Dec; 63(4):507-17. PubMed ID: 8642213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairments in multibacillary leprosy; a study from Brazil.
    Pimentel MI; Nery JA; Borges E; Gonçalves RR; Sarno EN
    Lepr Rev; 2004 Jun; 75(2):143-52. PubMed ID: 15282965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathic pain in people treated for multibacillary leprosy more than ten years previously.
    Saunderson P; Bizuneh E; Leekassa R
    Lepr Rev; 2008 Sep; 79(3):270-6. PubMed ID: 19009976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do nerve growth factor-related mechanisms contribute to loss of cutaneous nociception in leprosy?
    Facer P; Mann D; Mathur R; Pandya S; Ladiwala U; Singhal B; Hongo J; Sinicropi DV; Terenghi G; Anand P
    Pain; 2000 Mar; 85(1-2):231-8. PubMed ID: 10692623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to nerve growth factor reverse established tactile allodynia in rodent models of neuropathic pain without tolerance.
    Wild KD; Bian D; Zhu D; Davis J; Bannon AW; Zhang TJ; Louis JC
    J Pharmacol Exp Ther; 2007 Jul; 322(1):282-7. PubMed ID: 17431136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children].
    Wasilewska A; Zoch-Zwierz W; Tomaszewska B; Tenderenda E
    Pol Merkur Lekarski; 2005 Feb; 18(104):168-72. PubMed ID: 17877123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.